Pharma Journalist - Page 793 of 923 -

MSD Completes $5.8 Billion Terns Pharmaceuticals Acquisition

Madrigal Licenses Gene Therapy Candidate for MASH Treatment

Citius Oncology Secures $36.5M to Boost LYMPHIR Launch

Roivant Sciences and ArQule enter into License Agreement for Derazantinib in China

Xcovery initiates Phase 2 Clinical Trial for Ensartinib in Melanoma Patients with ALK Alternations

Capricor receives FDA RMAT Designation for Duchenne Muscular Dystrophy Therapy

FDA Clears Oricula Therapeutics Investigational New Drug Application for Clinical Trials

VER Pharma Adopts Veeva OpenData and Veeva CRM to Transform Customer Engagement

Shield reports top-line results from pivotal Phase III study of Feraccru

EMA accepts Teva’s Fremanezumab Marketing Authorization Application

Matthew M. Walsh appointed Executive Vice President and CFO of Allergan